Aseptic Manufacturing – Maintaining the validated state

Sponsored by

Conference description

This two-day intensive summit brings together the industry leaders in compliance, aseptic manufacturing and maintaining the validated state. The conference will go beyond presentations on best practice and consists of both presentations and workshops on different aspects of aseptic manufacturing. Attendees will therefore gain a deeper understanding of the new messages from the new Annex 1 draft, FDA focuses on inspecting sterile facilities, sterilisation, process validation, life cycle approach and more. The conference will showcase some of the tech that impacts aseptic manufacturing.

In addition to the many presentations and workshops, the conference will also provide many opportunities for networking. Read more about the individual presentations in the full agenda.

Conference outline

Download the full agenda with speaker presentations (updated 21 July 2021) →

Day 1
Moderator: Laurence O’Leary, ValidEire Aps

• Intro to Day 1 by Moderator
• EU Annex 1- Manufacture of Sterile Medicinal Products
  Pierre Devaux, Theraxel
• System Real Time Data Integrity, Electronic Sample Collection in Controlled Areas.
  Susan Cleary, Novatek International
• Plenary Q&A
• Validation of Lyophilisation for Parenterals
  Kirstie Goggin, MTL projects
• Equipment and Facility design of an Aseptic Facility
  Robert J. Hayes, SeerPharma (UK)
• Cleanroom and Contamination Control Strategy
  Pierre Devaux, Theraxel
• Plenary Q&A / Wrap up
• Snack and refreshments
  Complimentary of Novatek International

Day 2
Moderator: Pierre Devaux, Theraxel

• Intro to Day 2 by Moderator
• Media Fill studies
  Gavin Ross, Founder, GTR Pharma
• Aseptic training with VR
  Sebastian Scheler, CEO & Lead Psychologist, Innerspace
• Plenary Q&A
• Annex 1 & Environmental monitoring
  Matt Kite, Lighthouse Worldwide Solutions
• Temperature Mapping – Validation and Temperature Measurement
  Enrique Riis, Ellab
• Processing and transfer of primary packaging material for sterile production and transfer to the filling line
  Jana-Cathrien Müller, Atec Steritec GmbH
• Plenary Q&A / Wrap-up

Conference objectives

The objective of this conference is to provide participants with practical knowledge and understanding of regulatory requirements and techniques that can be put to use in their own aseptic manufacturing process strategy. The presenters will focus on the newest information available and will cover a wide range of subjects relevant to aseptic manufacturing and maintaining the validated stateThe objective of this conference is to provide participants with practical knowledge and understanding of regulatory requirements and techniques that can be put to use in their own aseptic manufacturing process strategy. The presenters will focus on the newest information available and will cover a wide range of subjects relevant to aseptic manufacturing and maintaining the validated state.

Who should attend

The conference is primarily relevant for R&D staff, Production Leaders, Supporters, Commissioning, Qualification and Validation teams and Quality Assurance seeking the latest knowledge about risk- and cross contamination control, as well as engineering companies wanting to learn more about the viewpoint of the pharmaceutical industry and exchanging experiences

#5255